Shares of Resverlogix Corp. (TSE:RVX – Get Free Report) crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of C$0.06 and traded as low as C$0.06. Resverlogix shares last traded at C$0.06, with a volume of 1,000 shares changing hands.
Resverlogix Trading Up 10.0 %
The company has a market capitalization of C$15.23 million, a PE ratio of -1.10 and a beta of 0.71. The business’s fifty day moving average is C$0.06 and its two-hundred day moving average is C$0.06.
Resverlogix Company Profile
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Recommended Stories
- Five stocks we like better than Resverlogix
- What Are the FAANG Stocks and Are They Good Investments?
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- What is the Shanghai Stock Exchange Composite Index?
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
